Peter Sellei
Analyst-Equity bei Erik Penser Bank AB
Profil
Peter Sellei currently works at Erik Penser Bank AB, as Analyst from 2021.
Dr. Sellei also formerly worked at Biovitrum AB, as Director, Swedish Orphan Biovitrum AB, as Director from 2009 to 2010, and Carnegie Investment Bank AB, as Analyst in 2003.
Aktive Positionen von Peter Sellei
| Unternehmen | Position | Beginn |
|---|---|---|
Erik Penser Bank AB
 Erik Penser Bank AB Investment Banks/BrokersFinance Part of Erik Penser AB, Erik Penser Bank AB is a brokerage services provider. The company is based in Stockholm, Sweden. The Swedish company was founded in 1965. Johan Mörner has been the CEO of the company since 2014. | Analyst-Equity | 01.03.2021 |
Ehemalige bekannte Positionen von Peter Sellei
| Unternehmen | Position | Ende |
|---|---|---|
Biovitrum AB
 Biovitrum AB Miscellaneous Commercial ServicesCommercial Services Biovitrum AB develops and sells specialist pharmaceuticals that improve people's lives. The company's business goal is to create a pharmaceutical company with long-term profitability through the international launch and sale of in-house developed products. Research expertise and capabilities are focused on development and production of biotechnology therapeutics within the prioritized areas of hemophilia, inflammation/autoimmune diseases, cancer supportive care and malabsorption. The company was founded in January 2001 and is headquartered in Stockholm, Sweden. | Direktor/Vorstandsmitglied | 27.04.2010 |
| SWEDISH ORPHAN BIOVITRUM AB | Direktor/Vorstandsmitglied | 26.04.2010 |
Carnegie Investment Bank AB
 Carnegie Investment Bank AB Investment Banks/BrokersFinance Carnegie Investment Bank AB is the broker/delear subsidiary of Carnegie Holding AB in Sweden. Headquartered in Stockholm, the firm was founded in 1803 and offers institutional clients several services within research, equity sales and equity capital market transactions (ECM). The Fixed Income unit offers bond research and sales. Carnegie Investment Bank’s research and equity sales enjoy a global position in Nordic equities. | Analyst-Equity | 23.04.2003 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| SWEDISH ORPHAN BIOVITRUM AB | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Biovitrum AB
Biovitrum AB Miscellaneous Commercial ServicesCommercial Services Biovitrum AB develops and sells specialist pharmaceuticals that improve people's lives. The company's business goal is to create a pharmaceutical company with long-term profitability through the international launch and sale of in-house developed products. Research expertise and capabilities are focused on development and production of biotechnology therapeutics within the prioritized areas of hemophilia, inflammation/autoimmune diseases, cancer supportive care and malabsorption. The company was founded in January 2001 and is headquartered in Stockholm, Sweden. | Commercial Services |
Carnegie Investment Bank AB
Carnegie Investment Bank AB Investment Banks/BrokersFinance Carnegie Investment Bank AB is the broker/delear subsidiary of Carnegie Holding AB in Sweden. Headquartered in Stockholm, the firm was founded in 1803 and offers institutional clients several services within research, equity sales and equity capital market transactions (ECM). The Fixed Income unit offers bond research and sales. Carnegie Investment Bank’s research and equity sales enjoy a global position in Nordic equities. | Finance |
Erik Penser Bank AB
Erik Penser Bank AB Investment Banks/BrokersFinance Part of Erik Penser AB, Erik Penser Bank AB is a brokerage services provider. The company is based in Stockholm, Sweden. The Swedish company was founded in 1965. Johan Mörner has been the CEO of the company since 2014. | Finance |
